Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis

Introduction Bronchiectasis is a long-term lung condition, with dilated bronchi, chronic inflammation, chronic infection and acute exacerbations. Recurrent exacerbations are associated with poorer clinical outcomes such as increased severity of lung disease, further exacerbations, hospitalisations,...

Full description

Bibliographic Details
Main Authors: John R Hurst, Adam T Hill, James D Chalmers, Anthony De Soyza, James Wason, Laura Ternent, Miranda Morton, Rebecca Maier, Graham Devereux, Rachel Lakey, Svetlana Cherlin, Nina Wilson, Adam Walker, CHARLES HAWORTH, Tara Marie Homer, Maria Allen, Alaa Abouhajar, Laura Simms, Alison Steel, Richard Joyce, Victoria Hildreth
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/8/e071906.full

Internet

https://bmjopen.bmj.com/content/13/8/e071906.full

Similar Items